These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20194836)

  • 1. Improving local control in rectal cancer: radiation sensitizers or radiation dose?
    Tepper JE; Wang AZ
    J Clin Oncol; 2010 Apr; 28(10):1623-4. PubMed ID: 20194836
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxaliplatin as a radiosensitizing agent in rectal cancer.
    Huerta S; Hrom J
    Anticancer Drugs; 2011 Apr; 22(4):317-23. PubMed ID: 21285866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which way is forward in the treatment of rectal cancer?
    Jansen RL; Beets GL
    Nat Rev Clin Oncol; 2013 Jan; 10(1):12-3. PubMed ID: 23229183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin-based combined-modality therapy for rectal cancer.
    Minsky BD
    Semin Oncol; 2003 Aug; 30(4 Suppl 15):26-33. PubMed ID: 14523792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oxaliplatin and preoperative chemoradiotherapy in rectal cancer].
    Ortholan C; Francois E; Follana P; Gérard JP
    Bull Cancer; 2006 Feb; 93 Suppl 1():S51-8. PubMed ID: 16483946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cisplatin and derivatives with radiation therapy: for what clinical use?].
    Durdux C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S88-94. PubMed ID: 15679253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer.
    Zhu AX; Willett CG
    Semin Radiat Oncol; 2003 Oct; 13(4):454-68. PubMed ID: 14586834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing neoadjuvant therapy for rectal cancer with oxaliplatin.
    Martin LK; Bekaii-Saab T
    J Natl Compr Canc Netw; 2013 Mar; 11(3):298-307; quiz 307. PubMed ID: 23486456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined-modality therapy of rectal cancer with oxaliplatin-based regimens.
    Minsky BD
    Clin Colorectal Cancer; 2004 Jun; 4 Suppl 1():S29-36. PubMed ID: 15212703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy for localized rectal cancer.
    Deutsch E; Ezra P; Mangoni M; Ducreux M
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix105-13. PubMed ID: 17631562
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of neoadjuvant concurrent chemioradiotherapy with oxaliplatin-containing regimen in locally advanced rectal cancer.
    Turitto G; Panelli G; Frattolillo A; Auriemma A; de Luna FS; Cione G; De Angelis CP; Muto P; Iaffaioli RV
    Front Biosci; 2006 May; 11():1275-9. PubMed ID: 16368513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of weekly oxaliplatin to standard preoperative chemoradiation for locally advanced rectal cancer.
    Aschele C; Lonardi S
    J Clin Oncol; 2007 Feb; 25(5):602-3; author reply 603. PubMed ID: 17290071
    [No Abstract]   [Full Text] [Related]  

  • 13. Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?
    Fakih MG
    Ann Oncol; 2006 Jun; 17(6):1029-30; author reply 1030-1. PubMed ID: 16384877
    [No Abstract]   [Full Text] [Related]  

  • 14. Gemcitabine radiosensitization for rectal cancer: step forward or dance step?
    O'Neil BH; Tepper JE
    Cancer J; 2005; 11(2):110-2. PubMed ID: 15969985
    [No Abstract]   [Full Text] [Related]  

  • 15. Infusional chemoradiation for rectal and anal cancers.
    Rich TA
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):131-4. PubMed ID: 10550837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].
    Créhange G; Bosset JF; Maingon P
    Cancer Radiother; 2011 Oct; 15(6-7):440-4. PubMed ID: 21802334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study.
    Machiels JP; Duck L; Honhon B; Coster B; Coche JC; Scalliet P; Humblet Y; Aydin S; Kerger J; Remouchamps V; Canon JL; Van Maele P; Gilbeau L; Laurent S; Kirkove C; Octave-Prignot M; Baurain JF; Kartheuser A; Sempoux C
    Ann Oncol; 2005 Dec; 16(12):1898-905. PubMed ID: 16219623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Principles of postoperative therapy in rectal carcinoma].
    Folprecht G; Köhne CH
    Chirurg; 2004 Jan; 75(1):32-7. PubMed ID: 14740125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results.
    Czito BG; Bendell JC; Willett CG; Morse MA; Blobe GC; Tyler DS; Thomas J; Ludwig KA; Mantyh CR; Ashton J; Yu D; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):472-8. PubMed ID: 17498568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of oxaliplatin to neo-adjuvant radiochemotherapy for irresectable rectal cancer, a phase I study.
    Reerink O; Mulder NH; Verschueren RC; Wiggers T; Szabo BG; Hospers GA
    Anticancer Res; 2005; 25(1B):629-33. PubMed ID: 15816638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.